Media Inquiries

The ADDF's science team includes experts in Alzheimer's disease and related dementias, neuroscience, geriatric medicine, drug discovery, and dementia prevention. They are available for comment on breaking news stories, research trends, and other topics.

To connect with an expert on staff, please contact Krishna Knabe, Director of Communications, at 212.901.7997.

Media Releases

March 7, 2017

$4 Million in New Grants Support Several First-in-Class Dementia Treatments

February 3, 2017

ADDF An Official Charity Partner of the 2017 TCS New York City Marathon

January 18, 2017

Expanded Partnership Increases Support for Drug Discovery

January 10, 2017

Mark Roithmayr Appointed As Our First CEO

Print